Interleukin 18 in the CNS

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Alboni, Silvia ^a   Cervia, Davide ^b   Sugama, Shuei ^c   Conti, Bruno ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF TUSCIA   (Italy)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 18 RECEPTOR BETA; INTERLEUKIN 8 RECEPTOR;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BRAIN FUNCTION; BRAIN TUMOR; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DEPRESSION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; ENCEPHALITIS; GENETIC ASSOCIATION; GLIOMA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MICROGLIA; MULTIPLE SCLEROSIS; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PARKINSONISM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA; STRESS; ANIMAL; CENTRAL NERVOUS SYSTEM; IMMUNOLOGY; INFLAMMATION; MENTAL DISEASE; MENTAL STRESS; METABOLISM; NEUROLOGIC DISEASE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; HUMANS; INFLAMMATION; INTERLEUKIN-18; MENTAL DISORDERS; MICROGLIA; NEURODEGENERATIVE DISEASES; RECEPTORS, INTERLEUKIN-8; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 77649177009     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-9     Document Type: Review

References (171)

1. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91. 10.1038/378088a0, 7477296.
2. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999, 103:11-24. 10.1016/S0091-6749(99)70518-X, 9893178.
3. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001, 12:53-72. 10.1016/S1359-6101(00)00015-0, 11312119.
4. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008, 223:20-38. 10.1111/j.1600-065X.2008.00624.x, 18613828.
5. Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur Cytokine Netw 2006, 17:224-252.
6. Park S, Cheon S, Cho D. The dual effects of interleukin-18 in tumor progression. Cell Mol Immunol 2007, 4:329-335.
7. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007, 27:98-114. 10.1016/j.semnephrol.2006.09.013, 17336692.
8. Dinarello CA, Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis 2003, 187(Suppl 2):S370-384. 10.1086/374751, 12792854.
9. Kawakami K. Interleukin-18 and host defense against infectious pathogens. J Immunother 2002, 25(Suppl 1):S12-19. 10.1097/00002371-200203001-00003, 12048346.
10. Netea MG, Joosten LA, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ, Tack CJ, van Krieken H, Kim SH, Stalenhoef AF, Loo FA, Verschueren I, Pulawa L, Akira S, Eckel RH, Dinarello CA, Berg W, Meer JW. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006, 12:650-656. 10.1038/nm1415, 16732281.
11. Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T, Conti B. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 2007, 104:11097-11102. 10.1073/pnas.0611523104, 1904154, 17578927.
12. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M, Okura T, Takakura-Yamamoto R, Torigoe K, Gu Y, Su MS, Fujii M, Satoh-Itoh M, Yamamoto K, Kohno K, Ikeda M, Kurimoto M. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J Biol Chem 1997, 272:26595-26603. 10.1074/jbc.272.42.26595, 9334240.
13. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 1998, 91:2118-2125.
14. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997, 386:619-623. 10.1038/386619a0, 9121587.
15. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997, 275:206-209. 10.1126/science.275.5297.206, 8999548.
16. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996, 156:4274-4279.
17. Fantuzzi G, Dinarello CA. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999, 19:1-11. 10.1023/A:1020506300324, 10080100.
18. Gracie JA. Interleukin-18 as a potential target in inflammatory arthritis. Clin Exp Immunol 2004, 136:402-404. 10.1111/j.1365-2249.2004.02475.x, 1809042, 15147340.
19. Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, Hanzawa K, Kumagai K, Okamura H, Takada H. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 2001, 167:6568-6575.
20. Conti B, Jahng JW, Tinti C, Son JH, Joh TH. Induction of interferon-gamma inducing factor in the adrenal cortex. J Biol Chem 1997, 272:2035-2037. 10.1074/jbc.272.4.2035, 8999896.
21. Yang YJ, Wang ZY, Chen SH, Ge XR. Cloning and characterization of a new isoform of mouse interleukin-18. Acta Biochim Biophys Sin (Shanghai) 2005, 37:826-834. 10.1111/j.1745-7270.2005.00116.x, 16331327.
22. O'Neill LA, Dinarello CA. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today 2000, 21:206-209. 10.1016/S0167-5699(00)01611-X, 10782049.
23. Sims JE. IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol 2002, 14:117-122. 10.1016/S0952-7915(01)00306-5, 11790541.
24. Sergi B, Penttila I. Interleukin 18 receptor. J Biol Regul Homeost Agents 2004, 18:55-61.
25. Thomassen E, Bird TA, Renshaw BR, Kennedy MK, Sims JE. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J Interferon Cytokine Res 1998, 18:1077-1088. 10.1089/jir.1998.18.1077, 9877452.
26. Alboni S, Cervia D, Ross B, Montanari C, Gonzalez AS, Sanchez-Alavez M, Marcondes MC, De Vries D, Sugama S, Brunello N, et al. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J Neuroimmunol 2009, 214:43-54. 10.1016/j.jneuroim.2009.06.016, 19640592.
27. Colotta F, Dower SK, Sims JE, Mantovani A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol Today 1994, 15:562-566. 10.1016/0167-5699(94)90217-8, 7848516.
28. Andre R, Wheeler RD, Collins PD, Luheshi GN, Pickering-Brown S, Kimber I, Rothwell NJ, Pinteaux E. Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J Neuroimmunol 2003, 145:40-45. 10.1016/j.jneuroim.2003.09.005, 14644029.
29. Fiszer D, Rozwadowska N, Rychlewski L, Kosicki W, Kurpisz M. Identification of IL-18RAP mRNA truncated splice variants in human testis and the other human tissues. Cytokine 2007, 39:178-183. 10.1016/j.cyto.2007.07.186, 17897836.
30. Im SH, Kim SH, Azam T, Venkatesh N, Dinarello CA, Fuchs S, Souroujon MC. Rat interleukin-18 binding protein: cloning, expression, and characterization. J Interferon Cytokine Res 2002, 22:321-328. 10.1089/107999002753675749, 12034039.
31. Kim SH, Azam T, Novick D, Yoon DY, Reznikov LL, Bufler P, Rubinstein M, Dinarello CA. Identification of amino acid residues critical for biological activity in human interleukin-18. J Biol Chem 2002, 277:10998-11003. 10.1074/jbc.M108311200, 11790772.
32. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136. 10.1016/S1074-7613(00)80013-8, 10023777.
33. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000, 97:1190-1195. 10.1073/pnas.97.3.1190, 15564, 10655506.
34. Bufler P, Azam T, Gamboni-Robertson F, Reznikov LL, Kumar S, Dinarello CA, Kim SH. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 2002, 99:13723-13728. 10.1073/pnas.212519099, 129755, 12381835.
35. Busfield SJ, Comrack CA, Yu G, Chickering TW, Smutko JS, Zhou H, Leiby KR, Holmgren LM, Gearing DP, Pan Y. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 2000, 66:213-216. 10.1006/geno.2000.6184, 10860666.
36. Kumar S, McDonnell PC, Lehr R, Tierney L, Tzimas MN, Griswold DE, Capper EA, Tal-Singer R, Wells GI, Doyle ML, Young PR. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 2000, 275:10308-10314. 10.1074/jbc.275.14.10308, 10744718.
37. Pan G, Risser P, Mao W, Baldwin DT, Zhong AW, Filvaroff E, Yansura D, Lewis L, Eigenbrot C, Henzel WJ, Vandlen R. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 2001, 13:1-7. 10.1006/cyto.2000.0799, 11145836.
38. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, Sims JE. Four new members expand the interleukin-1 superfamily. J Biol Chem 2000, 275:1169-1175. 10.1074/jbc.275.2.1169, 10625660.
39. Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. Genomic organization of the interleukin-1 locus. Genomics 2002, 79:726-733. 10.1006/geno.2002.6752, 11991723.
40. Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002, 18:61-71. 10.1006/cyto.2002.0873, 12096920.
41. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000, 11:483-486.
42. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003, 73:213-224. 10.1189/jlb.0602313, 12554798.
43. Shimoda K, Tsutsui H, Aoki K, Kato K, Matsuda T, Numata A, Takase K, Yamamoto T, Nukina H, Hoshino T, et al. Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice. Blood 2002, 99:2094-2099. 10.1182/blood.V99.6.2094, 11877284.
44. Kalina U, Kauschat D, Koyama N, Nuernberger H, Ballas K, Koschmieder S, Bug G, Hofmann WK, Hoelzer D, Ottmann OG. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J Immunol 2000, 165:1307-1313.
45. Chandrasekar B, Patel DN, Mummidi S, Kim JW, Clark RA, Valente AJ. Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation. J Biol Chem 2008, 283:4200-4209. 10.1074/jbc.M708142200, 18086672.
46. Fortin CF, Ear T, McDonald PP. Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils. Faseb J 2009, 23:194-203. 10.1096/fj.08-110213, 18780764.
47. Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 2008, 28:12775-12787. 10.1523/JNEUROSCI.3512-08.2008, 19036970.
48. Cumiskey D, Pickering M, O'Connor JJ. Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists. Neurosci Lett 2007, 412:206-210. 10.1016/j.neulet.2006.11.007, 17123727.
49. Curran BP, Murray HJ, O'Connor JJ. A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 2003, 118:347-357. 10.1016/S0306-4522(02)00941-7, 12699771.
50. Ojala JO, Sutinen EM, Salminen A, Pirttila T. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol 2008, 205:86-93. 10.1016/j.jneuroim.2008.09.012, 18947885.
51. Culhane AC, Hall MD, Rothwell NJ, Luheshi GN. Cloning of rat brain interleukin-18 cDNA. Mol Psychiatry 1998, 3:362-366. 10.1038/sj.mp.4000389, 9702748.
52. Wheeler RD, Culhane AC, Hall MD, Pickering-Brown S, Rothwell NJ, Luheshi GN. Detection of the interleukin 18 family in rat brain by RT-PCR. Brain Res Mol Brain Res 2000, 77:290-293. 10.1016/S0169-328X(00)00069-3, 10837926.
53. Andoh T, Kishi H, Motoki K, Nakanishi K, Kuraishi Y, Muraguchi A. Protective effect of IL-18 on kainate- and IL-1 beta-induced cerebellar ataxia in mice. J Immunol 2008, 180:2322-2328.
54. Nagai Y, Ogasawara H, Taketa Y, Aso H, Kanaya T, Miyake M, Watanabe K, Ohwada S, Muneta Y, Yamaguchi T. Expression of inflammatory-related factors in porcine anterior pituitary-derived cell line. Vet Immunol Immunopathol 2008, 124:201-208. 10.1016/j.vetimm.2008.03.007, 18440649.
55. Nagai Y, Ogasawara H, Taketa Y, Aso H, Tanaka S, Kanaya T, Watanabe K, Ohwada S, Muneta Y, Yamaguchi T. Bovine anterior pituitary progenitor cell line expresses interleukin (IL)-18 and IL-18 receptor. J Neuroendocrinol 2008, 20:1233-1241. 10.1111/j.1365-2826.2008.01779.x, 18761716.
56. Sugama S, Cho BP, Baker H, Joh TH, Lucero J, Conti B. Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res 2002, 958:1-9. 10.1016/S0006-8993(02)03363-2, 12468024.
57. Wang N, Sugama S, Conti B, Teramoto A, Shibasaki T. Interleukin-18 mRNA expression in the rat pituitary gland. J Neuroimmunol 2006, 173:117-125. 10.1016/j.jneuroim.2005.12.009, 16460811.
58. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson GE, Joh TH. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 1999, 67:46-52. 10.1016/S0169-328X(99)00034-0, 10101231.
59. Das S, Mishra MK, Ghosh J, Basu A. Japanese Encephalitis Virus infection induces IL-18 and IL-1beta in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. J Neuroimmunol 2008, 195:60-72. 10.1016/j.jneuroim.2008.01.009, 18374991.
60. Jeon GS, Park SK, Park SW, Kim DW, Chung CK, Cho SS. Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus. Neurochem Res 2008, 33:179-184. 10.1007/s11064-007-9434-6, 17710540.
61. Prinz M, Hanisch UK. Murine microglial cells produce and respond to interleukin-18. J Neurochem 1999, 72:2215-2218. 10.1046/j.1471-4159.1999.0722215.x, 10217305.
62. Sugama S, Fujita M, Hashimoto M, Conti B. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 2007, 146:1388-1399. 10.1016/j.neuroscience.2007.02.043, 17433555.
63. Suk K, Yeou Kim S, Kim H. Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes. Immunol Lett 2001, 77:79-85. 10.1016/S0165-2478(01)00209-7, 11377701.
64. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem 1996, 271:3967-3970. 10.1074/jbc.271.10.5777, 8626725.
65. Born TL, Thomassen E, Bird TA, Sims JE. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 1998, 273:29445-29450. 10.1074/jbc.273.45.29445, 9792649.
66. Otsuki M, Kusumoto K, Murakami Y, Kanayama M, Takeuchi S, Takahashi S. Expression of interleukin-18 receptor mRNA in the mouse endometrium. J Reprod Dev 2007, 53:59-68. 10.1262/jrd.18036, 17062984.
67. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002, 22:5910-5919.
68. Wheeler RD, Brough D, Le Feuvre RA, Takeda K, Iwakura Y, Luheshi GN, Rothwell NJ. Interleukin-18 induces expression and release of cytokines from murine glial cells: interactions with interleukin-1 beta. J Neurochem 2003, 85:1412-1420. 10.1046/j.1471-4159.2003.01787.x, 12787061.
69. Dantzer R, Bluthe RM, Gheusi G, Cremona S, Laye S, Parnet P, Kelley KW. Molecular basis of sickness behavior. Ann N Y Acad Sci 1998, 856:132-138. 10.1111/j.1749-6632.1998.tb08321.x, 9917873.
70. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007, 21:153-160. 10.1016/j.bbi.2006.09.006, 1850954, 17088043.
71. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56. 10.1038/nrn2297, 18073775.
72. Kubota T, Fang J, Brown RA, Krueger JM. Interleukin-18 promotes sleep in rabbits and rats. Am J Physiol Regul Integr Comp Physiol 2001, 281:R828-838.
73. Gatti S, Beck J, Fantuzzi G, Bartfai T, Dinarello CA. Effect of interleukin-18 on mouse core body temperature. Am J Physiol Regul Integr Comp Physiol 2002, 282:R702-709.
74. Cumiskey D, Curran BP, Herron CE, O'Connor JJ. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology 2007, 52:1616-1623. 10.1016/j.neuropharm.2007.03.006, 17459425.
75. Curran B, O'Connor JJ. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 2001, 108:83-90. 10.1016/S0306-4522(01)00405-5, 11738133.
76. Kanno T, Nagata T, Yamamoto S, Okamura H, Nishizaki T. Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices. Brain Res 2004, 1012:190-193. 10.1016/j.brainres.2004.03.065, 15158178.
77. Yaguchi T, Nagata T, Yang D, Nishizaki T. Interleukin-18 regulates motor activity, anxiety and spatial learning without affecting synaptic plasticity. Behav Brain Res 2010, 206:47-51. 10.1016/j.bbr.2009.08.033, 19729040.
78. Sugama S, Conti B. Interleukin-18 and stress. Brain Res Rev 2008, 58:85-95. 10.1016/j.brainresrev.2007.11.003, 18295340.
79. Sekiyama A, Ueda H, Kashiwamura S, Nishida K, Kawai K, Teshima-kondo S, Rokutan K, Okamura H. IL-18; a cytokine translates a stress into medical science. J Med Invest 2005, 52(Suppl):236-239. 10.2152/jmi.52.236, 16366505.
80. Nagai Y, Nochi T, Watanabe K, Aso H, Kitazawa H, Matsuzaki M, Ohwada S, Yamaguchi T. Localization of interleukin-18 and its receptor in somatotrophs of the bovine anterior pituitary gland. Cell Tissue Res 2005, 322:455-462. 10.1007/s00441-005-0016-0, 16001266.
81. Tringali G, Pozzoli G, Vairano M, Mores N, Preziosi P, Navarra P. Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis. J Neuroimmunol 2005, 160:61-67. 10.1016/j.jneuroim.2004.10.028, 15710458.
82. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration?. Trends Neurosci 2005, 28:487-493. 10.1016/j.tins.2005.06.008, 16023742.
83. Abulafia DP, de Rivero Vaccari JP, Lozano JD, Lotocki G, Keane RW, Dietrich WD. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab 2009, 29:534-544. 10.1038/jcbfm.2008.143, 19066616.
84. Qiu L, Zhu C, Wang X, Xu F, Eriksson PS, Nilsson M, Cooper-Kuhn CM, Kuhn HG, Blomgren K. Less neurogenesis and inflammation in the immature than in the juvenile brain after cerebral hypoxia-ischemia. J Cereb Blood Flow Metab 2007, 27:785-794.
85. Mori I, Hossain MJ, Takeda K, Okamura H, Imai Y, Kohsaka S, Kimura Y. Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 2001, 287:163-170. 10.1006/viro.2001.1029, 11504551.
86. Jander S, Schroeter M, Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J Cereb Blood Flow Metab 2002, 22:62-70. 10.1097/00004647-200201000-00008, 11807395.
87. de Rivero Vaccari JP, Lotocki G, Marcillo AE, Dietrich WD, Keane RW. A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci 2008, 28:3404-3414. 10.1523/JNEUROSCI.0157-08.2008, 18367607.
88. Xie WR, Deng H, Li H, Bowen TL, Strong JA, Zhang JM. Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience 2006, 142:809-822. 10.1016/j.neuroscience.2006.06.045, 1661830, 16887276.
89. Jander S, Stoll G. Differential induction of interleukin-12, interleukin-18, and interleukin-1beta converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat. J Neuroimmunol 1998, 91:93-99. 10.1016/S0165-5728(98)00162-3, 9846824.
90. Wildbaum G, Youssef S, Grabie N, Karin N. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J Immunol 1998, 161:6368-6374.
91. Shi FD, Takeda K, Akira S, Sarvetnick N, Ljunggren HG. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J Immunol 2000, 165:3099-3104.
92. Schif-Zuck S, Westermann J, Netzer N, Zohar Y, Meiron M, Wildbaum G, Karin N. Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells. J Immunol 2005, 174:4307-4315.
93. Gutcher I, Urich E, Wolter K, Prinz M, Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat Immunol 2006, 7:946-953. 10.1038/ni1377, 16906165.
94. Thessen Hedreul M, Gillett A, Olsson T, Jagodic M, Harris RA. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J Neuroimmunol 2009, 210:30-39. 10.1016/j.jneuroim.2009.02.010, 19269041.
95. Huang WX, Huang P, Hillert J. Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis. Mult Scler 2004, 10:482-487. 10.1191/1352458504ms1071oa, 15471361.
96. Karni A, Koldzic DN, Bharanidharan P, Khoury SJ, Weiner HL. IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J Neuroimmunol 2002, 125:134-140. 10.1016/S0165-5728(02)00018-8, 11960649.
97. Losy J, Niezgoda A. IL-18 in patients with multiple sclerosis. Acta Neurol Scand 2001, 104:171-173. 10.1034/j.1600-0404.2001.00356.x, 11551238.
98. Nicoletti F, Di Marco R, Mangano K, Patti F, Reggio E, Nicoletti A, Bendtzen K, Reggio A. Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology 2001, 57:342-344.
99. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999, 96:6873-6878. 10.1073/pnas.96.12.6873, 22009, 10359806.
100. Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol 1999, 163:2403-2409.
101. Furlan R, Filippi M, Bergami A, Rocca MA, Martinelli V, Poliani PL, Grimaldi LM, Desina G, Comi G, Martino G. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. J Neurol Neurosurg Psychiatry 1999, 67:785-788. 10.1136/jnnp.67.6.785, 1736665, 10567499.
102. Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J Virol 2001, 75:9780-9789. 10.1128/JVI.75.20.9780-9789.2001, 114550, 11559811.
103. Caselli RJ, Beach TG, Yaari R, Reiman EM. Alzheimer's disease a century later. J Clin Psychiatry 2006, 67:1784-1800. 10.4088/JCP.v67n1118, 17196061.
104. Griffin WS. Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006, 83:470S-474S.
105. Aarli JA. Role of cytokines in neurological disorders. Curr Med Chem 2003, 10:1931-1937. 10.2174/0929867033456918, 12871095.
106. Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttila T. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging 2009, 30:198-209. 10.1016/j.neurobiolaging.2007.06.006, 17658666.
107. Malaguarnera L, Motta M, Di Rosa M, Anzaldi M, Malaguarnera M. Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia. Neuropathology 2006, 26:307-312. 10.1111/j.1440-1789.2006.00701.x, 16961066.
108. Ozturk C, Ozge A, Yalin OO, Yilmaz IA, Delialioglu N, Yildiz C, Tesdelen B, Kudiaki C. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline. Behav Neurol 2007, 18:207-215.
109. Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett 2007, 114:46-51. 10.1016/j.imlet.2007.09.002, 17949824.
110. Lindberg C, Chromek M, Ahrengart L, Brauner A, Schultzberg M, Garlind A. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Neurochem Int 2005, 46:551-557. 10.1016/j.neuint.2005.01.004, 15843049.
111. Bossu P, Ciaramella A, Salani F, Bizzoni F, Varsi E, Di Iulio F, Giubilei F, Gianni W, Trequattrini A, Moro ML, et al. Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment. Brain Behav Immun 2008, 22:487-492. 10.1016/j.bbi.2007.10.001, 17988833.
112. Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci 2006, 23:2648-2656. 10.1111/j.1460-9568.2006.04780.x, 16817867.
113. Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, Tian Y. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res 2009, 1253:169-175. 10.1016/j.brainres.2008.11.083, 19073159.
114. Bossu P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, et al. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007, 78:807-811. 10.1136/jnnp.2006.103242, 17299019.
115. Segat L, Milanese M, Arosio B, Vergani C, Crovella S. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease. Neurobiol Aging 2008, 31:162-164. 10.1016/j.neurobiolaging.2008.03.005, 18433937.
116. Iannello A, Samarani S, Debbeche O, Tremblay C, Toma E, Boulassel MR, Routy JP, Ahmad A. Role of interleukin-18 in the development and pathogenesis of AIDS. AIDS Rev 2009, 11:115-125.
117. Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Neuroscience 2004, 128:451-458. 10.1016/j.neuroscience.2004.07.020, 15350655.
118. Corcos M, Guilbaud O, Hjalmarsson L, Chambry J, Jeammet P. Cytokines and depression: an analogic approach. Biomed Pharmacother 2002, 56:105-110. 10.1016/S0753-3322(01)00156-1, 12000135.
119. Dinan TG. Inflammatory markers in depression. Curr Opin Psychiatry 2009, 22:32-36. 10.1097/YCO.0b013e328315a561, 19122532.
120. Ganguli R, Yang Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, Rabin BS. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994, 51:1-10. 10.1016/0165-1781(94)90042-6, 7910974.
121. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999, 4:317-327. 10.1038/sj.mp.4000586, 10483047.
122. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003, 61:519-525. 10.1016/S0306-9877(03)00207-X, 14592780.
123. Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 2007, 7:46. 10.1186/1471-244X-7-46, 2080573, 17822540.
124. Appels A, Bar FW, Bar J, Bruggeman C, de Baets M. Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med 2000, 62:601-605.
125. Eisner MD, Katz PP, Lactao G, Iribarren C. Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 2005, 94:566-574.
126. Muller N, Gizycki-Nienhaus B, Gunther W, Meurer M. Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid. Biol Psychiatry 1992, 31:1151-1156. 10.1016/0006-3223(92)90160-2, 1525278.
127. O'Reilly RL, Singh SM. Retroviruses and schizophrenia revisited. Am J Med Genet 1996, 67:19-24. 10.1002/(SICI)1096-8628(19960216)67:1<19::AID-AJMG3>3.0.CO;2-N, 8678109.
128. Muller N, Strassnig M, Schwarz MJ, Ulmschneider M, Riedel M. COX-2 inhibitors as adjunctive therapy in schizophrenia. Expert Opin Investig Drugs 2004, 13:1033-1044. 10.1517/13543784.13.8.1033, 15268640.
129. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003, 28:1182-1185.
130. Jun TY, Pae CU, Hoon H, Chae JH, Bahk WM, Kim KS, Serretti A. Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet 2003, 13:179-181. 10.1097/00041444-200309000-00008, 12960751.
131. Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 2008, 28:13957-13966. 10.1523/JNEUROSCI.4457-08.2008, 2752712, 19091984.
132. Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 2009, 3:14. 10.3389/neuro.08.014.2009, 2737431, 19738918.
133. Kroes RA, Panksepp J, Burgdorf J, Otto NJ, Moskal JR. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience 2006, 137:37-49. 10.1016/j.neuroscience.2005.08.076, 16289586.
134. Lu LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. Di Yi Jun Yi Da Xue Xue Bao 2004, 24:1251-1254.
135. Tanaka KF, Shintani F, Fujii Y, Yagi G, Asai M. Serum interleukin-18 levels are elevated in schizophrenia. Psychiatry Res 2000, 96:75-80. 10.1016/S0165-1781(00)00196-7, 10980328.
136. Kokai M, Kashiwamura S, Okamura H, Ohara K, Morita Y. Plasma interleukin-18 levels in patients with psychiatric disorders. J Immunother 2002, 25(Suppl 1):S68-71. 10.1097/00002371-200203001-00011, 12048354.
137. Merendino RA, Di Rosa AE, Di Pasquale G, Minciullo PL, Mangraviti C, Costantino A, Ruello A, Gangemi S. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm 2002, 11:265-267. 10.1080/096293502900000131, 1781663, 12396479.
138. Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006, 11:984-991. 10.1038/sj.mp.4001879, 16894392.
139. Bossu P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F, Rasura M, Caltagirone C, Robinson RG, Orzi F, Spalletta G. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res 2009, 6:163-170. 10.2174/156720209788970036, 19534720.
140. Fang J, Cheng Q. Etiological mechanisms of post-stroke depression: a review. Neurol Res 2009, 31:904-909. 10.1179/174313209X385752, 19891854.
141. Sugama S, Kim Y, Baker H, Tinti C, Kim H, Joh TH, Conti B. Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J Immunol 2000, 165:6287-6292.
142. Sugama S, Wang N, Shimokawa N, Koibuchi N, Fujita M, Hashimoto M, Dhabhar FS, Conti B. The adrenal gland is a source of stress-induced circulating IL-18. J Neuroimmunol 2006, 172:59-65. 10.1016/j.jneuroim.2005.11.001, 16359733.
143. Sekiyama A, Ueda H, Kashiwamura S, Nishida K, Yamaguchi S, Sasaki H, Kuwano Y, Kawai K, Teshima-Kondo S, Rokutan K, Okamura H. A role of the adrenal gland in stress-induced up-regulation of cytokines in plasma. J Neuroimmunol 2006, 171:38-44. 10.1016/j.jneuroim.2005.09.010, 16253346.
144. Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?. Am J Psychiatry 1993, 150:1189-1193.
145. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 1993, 49:11-27. 10.1016/0165-1781(93)90027-E, 7511248.
146. Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999, 140:4359-4366. 10.1210/en.140.9.4359, 10465310.
147. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999, 20:435-459. 10.1210/er.20.4.435, 10453354.
148. Wang X, Wu H, Miller AH. Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol Psychiatry 2004, 9:65-75. 10.1038/sj.mp.4001339, 14699442.
149. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008, 31:464-468. 10.1016/j.tins.2008.06.006, 18675469.
150. Zhang XM, Duan RS, Chen Z, Quezada HC, Mix E, Winblad B, Zhu J. IL-18 deficiency aggravates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice due to an overcompensation by IL-12. Exp Neurol 2007, 205:64-73. 10.1016/j.expneurol.2007.01.019, 17316614.
151. Sarin H. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med 2009, 7:77. 10.1186/1479-5876-7-77, 2743638, 19723323.
152. Kito T, Kuroda E, Yokota A, Yamashita U. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-gamma-regulated nitric oxide. J Neurosurg 2003, 98:385-392. 10.3171/jns.2003.98.2.0385, 12593627.
153. Kikuchi T, Akasaki Y, Joki T, Abe T, Kurimoto M, Ohno T. Antitumor activity of interleukin-18 on mouse glioma cells. J Immunother 2000, 23:184-189. 10.1097/00002371-200003000-00002, 10746544.
154. Yamanaka R, Tsuchiya N, Yajima N, Honma J, Hasegawa H, Tanaka R, Ramsey J, Blaese RM, Xanthopoulos KG. Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12. J Neurosurg 2003, 99:746-753. 10.3171/jns.2003.99.4.0746, 14567611.
155. Yamanaka R, Yajima N, Tsuchiya N, Honma J, Tanaka R, Ramsey J, Blaese M, Xanthopoulos KG. Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA. J Neurosurg 2002, 97:1184-1190. 10.3171/jns.2002.97.5.1184, 12450042.
156. Zhang Y, Wang C, Sun M. C6 glioma cells retrovirally engineered to express IL-18 and Fas exert FasL-dependent cytotoxicity against glioma formation. Biochem Biophys Res Commun 2004, 325:1240-1245. 10.1016/j.bbrc.2004.10.165, 15555559.
157. Xu G, Jiang XD, Xu Y, Zhang J, Huang FH, Chen ZZ, Zhou DX, Shang JH, Zou YX, Cai YQ, et al. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biol Int 2009, 33:466-474. 10.1016/j.cellbi.2008.07.023, 18725309.
158. Matsui K, Yoshimoto T, Tsutsui H, Hyodo Y, Hayashi N, Hiroishi K, Kawada N, Okamura H, Nakanishi K, Higashino K. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997, 159:97-106.
159. Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk AH. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 1997, 159:298-302.
160. Liu YP, Lin HI, Tzeng SF. Tumor necrosis factor-alpha and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture. Brain Res 2005, 1054:152-158. 10.1016/j.brainres.2005.06.085, 16054598.
161. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999, 96:25-34. 10.1016/S0092-8674(00)80956-3, 9989494.
162. Li S, Goorha S, Ballou LR, Blatteis CM. Intracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: pyrogenic and PGE(2)-mediated?. Brain Res 2003, 992:76-84. 10.1016/j.brainres.2003.08.033, 14604775.
163. Kumar RA, Cann C, Hall JE, Sudheer PS, Wilkes AR. Predictive value of IL-18 and SC5b-9 for neurocognitive dysfunction after cardiopulmonary bypass. Br J Anaesth 2007, 98:317-322. 10.1093/bja/ael366, 17227817.
164. Yatsiv I, Morganti-Kossmann MC, Perez D, Dinarello CA, Novick D, Rubinstein M, Otto VI, Rancan M, Kossmann T, Redaelli CA, et al. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab 2002, 22:971-978. 10.1097/00004647-200208000-00008, 12172382.
165. Hedtjarn M, Mallard C, Arvidsson P, Hagberg H. White matter injury in the immature brain: role of interleukin-18. Neurosci Lett 2005, 373:16-20. 10.1016/j.neulet.2004.09.062, 15555769.
166. Hedtjarn M, Mallard C, Iwakura Y, Hagberg H. Combined deficiency of IL-1beta18, but not IL-1alphabeta, reduces susceptibility to hypoxia-ischemia in the immature brain. Dev Neurosci 2005, 27:143-148. 10.1159/000085986, 16046848.
167. Zhu C, Qiu L, Wang X, Xu F, Nilsson M, Cooper-Kuhn C, Kuhn HG, Blomgren K. Age-dependent regenerative responses in the striatum and cortex after hypoxia-ischemia. J Cereb Blood Flow Metab 2009, 29:342-354. 10.1038/jcbfm.2008.124, 18985054.
168. Fukui O, Kinugasa Y, Fukuda A, Fukuda H, Tskitishvili E, Hayashi S, Song M, Kanagawa T, Hosono T, Shimoya K, Murata Y. Post-ischemic hypothermia reduced IL-18 expression and suppressed microglial activation in the immature brain. Brain Res 2006, 1121:35-45. 10.1016/j.brainres.2006.08.121, 17010950.
169. Zaremba J, Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 2003, 24:117-124. 10.1007/s10072-003-0096-0, 14600822.
170. Abdul-Careem MF, Hunter BD, Sarson AJ, Mayameei A, Zhou H, Sharif S. Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system. Viral Immunol 2006, 19:167-176. 10.1089/vim.2006.19.167, 16817759.
171. von Giesen HJ, Jander S, Koller H, Arendt G. Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease. J Neurovirol 2004, 10:383-386. 10.1080/13550280490523706, 15765809.